Efficacy and safety of sofosbuvir plus simeprevir in patients with advanced HCV cirrhosis

被引：0
|
作者：
Capraru, Camelia I. [1 ]
Kuczynski, Magdalena [1 ]
La, Danie [1 ]
Kaznowski, Diana [1 ]
Kowgier, Matthew [1 ]
Wong, David K. [1 ]
Juan, Joshua [1 ]
Shah, Hemant [1 ]
Ramji, Alnoor [2 ]
Janssen, Harry L. [1 ]
Feld, Jordan J. [1 ]
机构：
[1] Toronto Western Hosp, Univ Hlth Network, Liver Clin, Toronto, ON M5T 2S8, Canada
[2] Gastrointestinal Res Inst, Vancouver, BC, Canada
来源：
HEPATOLOGY | 2014年 / 60卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
963
引用
收藏
页码：665A / 665A
页数：1
相关论文
共 50 条
  • [41] Sofosbuvir in Combination with Simeprevir plus /- Ribavirin in Genotype 4 Hepatitis C Patients with Advanced Fibrosis or Cirrhosis: A Real-World Experience from Belgium
    Degre, Delphine
    Serste, Thomas
    Lasser, Luc
    Delwaide, Jean
    Starkel, Peter
    Laleman, Wim
    Langlet, Philippe
    Reynaert, Hendrik
    Bourgeois, Stefan
    Vanwolleghem, Thomas
    Dastis, Sergio Negrin
    Gustot, Thierry
    Geerts, Anja
    Van Steenkiste, Christophe
    De Galocsy, Chantal
    Lepida, Antonia
    Orlent, Hans
    Moreno, Christophe
    [J]. PLOS ONE, 2017, 12 (01):
  • [42] Daclatasvir (DCV) plus Sofosbuvir (SOF) regimens in chronic Hepatitis C Virus (HCV) infected patients with advanced fibrosis or cirrhosis
    Elefsiniotis, Loannis S.
    Dalekos, George N.
    Koskinas, John
    Ioannidou, Panagiota
    Cholongitas, Evangelos
    Manolakopoulos, Spilios
    Goulis, John
    Vlachogiannakos, John
    Deutsch, Melani
    Triantos, Christos K.
    Kapatais, Andreas
    Sevastianos, Vassilios A.
    Schina, Maria J.
    Karatapanis, Stylianos
    Ketikoglou, Loannis
    Manesis, Emanuel K.
    Papageorgiou, Maria-Vasiliki
    Sinakos, Emanuel
    Gatselis, Nikolaos K.
    Karagiannakis, Dimitrios
    Tasovasili, Athanasia
    Koukoufiki, Argyro
    Voulgaris, Theodoros A.
    Tsolias, Chrysostomos
    Akriviadis, Evangelos
    Papatheodoridis, George V.
    [J]. HEPATOLOGY, 2016, 64 : 990A - 991A
  • [43] Hepatic decompensation with sofosbuvir plus simeprevir in a patient with Child-Pugh B compensated cirrhosis
    Soriano, Vincent
    Barreiro, Pablo
    de Mendoza, Carmen
    Pena, Jose M.
    [J]. ANTIVIRAL THERAPY, 2016, 21 (01) : 91 - 92
  • [44] Daclatasvir Plus Sofosbuvir Plus Ribavirin for 12 or 16 Weeks in Treatment-Experienced Patients With HCV Genotype 3 Infection and Advanced Fibrosis or Cirrhosis
    Hezode, Christophe
    Dore, Gregory J.
    Pianko, Stephen
    Pol, Stanislas
    Stuart, Katherine
    Thompson, Alexander
    Tse, Edmund
    Bhore, Rafia
    Jimenez-Exposito, Maria Jesus
    [J]. GASTROENTEROLOGY, 2016, 150 (04) : S1096 - S1096
  • [45] Safety and Efficacy of Sofosbuvir (SOF) in Combination with Simeprevir (SIM) plus Ribavirin (RBV) in Patients with Genotype 1: Interim Results of a Prospective, Observational Study
    Sulkowski, Mark S.
    Vargas, Hugo E.
    Di Bisceglie, Adrian M.
    Kuo, Alexander
    Reddy, K. Rajender
    Lim, Joseph K.
    Morelli, Giuseppe
    Feld, Jordan J.
    Brown, Robert S.
    Frazier, Lynn M.
    Fried, Michael W.
    Nelson, David R.
    Jacobson, Ira M.
    [J]. HEPATOLOGY, 2014, 60 : 660A - 661A
  • [46] DACLATASVIR PLUS SOFOSBUVIR PLUS RIBAVIRIN FOR 12 OR 16 WEEKS IN TREATMENT-EXPERIENCED PATIENTS WITH HCV GENOTYPE 3 INFECTION AND ADVANCED FIBROSIS OR CIRRHOSIS
    Hezode, C.
    Dore, G.
    Pianko, S.
    Pol, S.
    Stuart, K.
    Thompson, A.
    Tse, E.
    Bhore, R.
    Jimenez-Exposito, M. J.
    [J]. JOURNAL OF HEPATOLOGY, 2016, 64 : S753 - S754
  • [47] Safety and Efficacy of Sofosbuvir in Combination with Daclatasvir or Simeprevir With or Without Ribavirin in the Treatment of Chronic HCV Genotype 4-infected Patients: A Real World Experience
    Babatin, Mohamed A.
    Albenmousa, Ali H.
    Alothmani, Hammad S.
    Alghamdi, Abdullah S.
    Bzeizi, Khalid I.
    Aljaroudi, Mandi E.
    Albiladi, Haziz
    Alsahafi, Ashwaq
    Sanai, Faisal M.
    [J]. HEPATOLOGY, 2016, 64 : 999A - 1000A
  • [48] Safety and Efficacy of Hepatitis C Therapy with Sofosbuvir and Simeprevir after Liver Transplantation
    Gutierrez, Julio A.
    Grigorian, Alla
    Carrion, Andres F.
    Schweitzer, Michael D.
    Avalos, Danny J.
    Bhamidimarri, Kalyan R.
    Peyton, Adam
    [J]. HEPATOLOGY, 2014, 60 : 545A - 545A
  • [49] Gender Differences in Patients Treated for HCV: Efficacy and Safety of Sofosbuvir/Velpatasvir in Women
    Tran, Tram T.
    Feld, Jordan J.
    Foster, Graham R.
    Naik, Sarjita
    Eggleton, Edward S.
    Zhang, Jie
    Natha, Macky
    Llewellyn, Joseph
    Kreter, Bruce
    Brainard, Diana M.
    Wyles, David L.
    Sulkowski, Mark S.
    Rogal, Shari S.
    [J]. HEPATOLOGY, 2016, 64 : 422A - 422A
  • [50] Efficacy and safety of ledipasvir/sofosbuvir therapy in HCV genotype 1 Korean patients
    Kang, Wonseok
    Sinn, Dong Hyun
    Gwak, Geum-Youn
    Paik, Yong-Han
    Choi, Moon Seok
    Lee, Joon Hyeok
    Koh, Kwang Cheol
    Paik, Seung Woon
    [J]. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2017, 32 : 194 - 194
12345